Preclinical assessments of the MEK inhibitor PD-0325901 in a mouse model of neurofibromatosis type 1

Abstract excerpt

BACKGROUND: Neurofibromatosis type 1 (NF1) is a genetic disorder that predisposes affected individuals to formation of benign neurofibromas, peripheral nerve tumors that can be associated with significant morbidity. Loss of the NF1 Ras-GAP protein causes increased Ras-GTP, and we previously found that inhibiting MEK signaling downstream of Ras can shrink established neurofibromas in a genetically engineered...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Melanoma and MAPK Pathways
• Share to Neuroblastoma Research and Treatments
• Share to Neurofibromatosis and Schwannoma Cases